Tauopathies, including AD, CBD, and PSP, arise from convergent pathogenic processes encompassing Tau hyperphosphorylation 46–48, impaired proteostasis 49,50, synaptic dysfunction 51,52, and chronic neuroinflammation 4,5. This evidence concerns the gene MAPT and Alzheimer disease.